These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

769 related articles for article (PubMed ID: 19149849)

  • 1. Central venous access devices for paediatric patients with haemophilia: a single-institution experience.
    Titapiwatanakun R; Moir C; Pruthi RK; Stavlo PL; Schmidt KA; Rodriguez V
    Haemophilia; 2009 Jan; 15(1):168-74. PubMed ID: 19149849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of the use of implantable venous access devices in the management of children with inherited bleeding disorders.
    Komvilaisak P; Connolly B; Naqvi A; Blanchette V
    Haemophilia; 2006 Dec; 12 Suppl 6():87-93. PubMed ID: 17123400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central venous access catheters in children with haemophilia.
    Blanchette VS; al-Musa A; Stain AM; Filler RM; Ingram J
    Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S39-44. PubMed ID: 8735796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monthly recombinant tissue plasminogen activator administration to implantable central venous access devices decreases infections in children with haemophilia.
    Jeng MR; O'Brien M; Wong W; Zoland J; Lea J; Tang N; Glader B
    Haemophilia; 2009 Nov; 15(6):1272-80. PubMed ID: 19601989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of prophylaxis and immune tolerance induction regimens in haemophilic children using fully implantable central venous catheters.
    Mancuso ME; Mannucci PM; Sartori A; Agliardi A; Santagostino E
    Br J Haematol; 2008 May; 141(5):689-95. PubMed ID: 18410458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central venous access device-related infections in patients with haemophilia.
    Yeoh ZH; Furmedge J; Ekert J; Crameri J; Curtis N; Barnes C
    J Paediatr Child Health; 2013 Mar; 49(3):242-5. PubMed ID: 23438133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of implantable venous access devices in children with severe hemophilia: benefits and burden.
    Van Dijk K; Van Der Bom JG; Bax KN; Van Der Zee DC; Van Den Berg MH
    Haematologica; 2004 Feb; 89(2):189-94. PubMed ID: 15003894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central venous access devices in children with hemophilia: an update.
    Blanchette VS; Al-Musa A; Stain AM; Ingram J; Fille RM
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S11-4. PubMed ID: 9351530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus recommendations for use of central venous access devices in haemophilia.
    Ewenstein BM; Valentino LA; Journeycake JM; Tarantino MD; Shapiro AD; Blanchette VS; Hoots WK; Buchanan GR; Manco-Johnson MJ; Rivard GE; Miller KL; Geraghty S; Maahs JA; Stuart R; Dunham T; Navickis RJ
    Haemophilia; 2004 Sep; 10(5):629-48. PubMed ID: 15357790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal central venous catheter-related infection in haemophilia.
    Crary SE; Buchanan GR; Journeycake JM
    Haemophilia; 2006 Mar; 12(2):183-6. PubMed ID: 16476095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS).
    Langley AR; Stain AM; Chan A; McLimont M; Chait S; Wu J; Poon MC; Card R; Israels SJ; Laferriere N; Klaassen RJ; Rivard GE; Cloutier S; Hawes S; Feldman B; Blanchette V
    Haemophilia; 2015 Jul; 21(4):469-76. PubMed ID: 26104147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethanol lock therapy for the treatment of catheter-related infections in haemophilia patients.
    Rajpurkar M; Boldt-Macdonald K; McLenon R; Callaghan MU; Chitlur M; Lusher JM; Becker C
    Haemophilia; 2009 Nov; 15(6):1267-71. PubMed ID: 19659937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing factor prophylaxis for the haemophilia population: where do we stand?
    Blanchette VS; Manco-Johnson M; Santagostino E; Ljung R
    Haemophilia; 2004 Oct; 10 Suppl 4():97-104. PubMed ID: 15479380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central venous access device associated infections: recommendations for best practice in home infusion therapy.
    Gorski LA
    Home Healthc Nurse; 2010 Apr; 28(4):221-9. PubMed ID: 20520262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central venous access device infections in children with hemophilia: a comparison of prophylaxis and episodic therapy.
    Hacker MR; Page JH; Shapiro AD; Rich-Edwards JW; Manco-Johnson MJ
    J Pediatr Hematol Oncol; 2007 Jul; 29(7):458-64. PubMed ID: 17609623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of central venous catheters in haemophilia patients.
    Izzi G; Franchini M; Bonetti L; Tagliaferri A
    Haemophilia; 2010 Jan; 16 Suppl 1():29-31. PubMed ID: 20059567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications of central venous access devices in paediatric haemophilia patients.
    Domm JA; Hudson MG; Janco RL
    Haemophilia; 2003 Jan; 9(1):50-6. PubMed ID: 12558778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of traditional vs. Canadian tailored prophylaxis dosing of prophylactic factor infusions in children with haemophilia A and B in a single hemophilia treatment center.
    Dodd C; Watts RG
    Haemophilia; 2012 Jul; 18(4):561-7. PubMed ID: 22221939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous access in haemophilic children: choice and management.
    Santagostino E; Mancuso ME
    Haemophilia; 2010 Jan; 16 Suppl 1():20-4. PubMed ID: 20059565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance of infectious complications associated with central venous access devices in children with haemophilia.
    Tarantino MD; Lail A; Donfield SM; Lynn H; Peddle L; Hunsberger S; Shapiro AD
    Haemophilia; 2003 Sep; 9(5):588-92. PubMed ID: 14511299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.